Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lee, Ho Sup  [Clear All Filters]
2023
Kim DJung, Jeong S, Kong SGim, Lee S, Lim S-N, Oh SYong, Do YRok, Lee WSik, Lee MHong, Bae SHwa, et al. Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea. Sci Rep. 2023;13(1):2551.
2021
Kong SGim, Lee J-H, Lim YTak, Lee JHyun, Eom H-S, Lee H, Kim DYoung, Lim S-N, Yoon S-S, Kim S-Y, et al. Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide. Korean J Intern Med. 2021.
2020
Kim KHa, Kim WSeog, Kim SJin, Yoon DHyun, Suh C, Kang HJin, Choi CWon, Lee HSup, Bae SHwa, Park J, et al. Treatment with Intravenous Busulfan, Melphalan, and Etoposide (BuME) followed by Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from the Consortium for Improving Survival of Lymphoma (CISL). Transpl Int. 2020.
2018
Lee G-W, Park SWoo, Go S-I, Kim H-G, Kim MKyoung, Min C-K, Kwak J-Y, Bae S-B, Yoon S-S, Lee J-J, et al. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 2018;140(3):146-156.
2015
Shin H-J, Yoon DHyun, Lee HSup, Oh SYong, Yang DHwan, Kang HJin, Chong SYoung, Park Y, Do YR, Lim S-N, et al. Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B cell lymphoma patients. Exp Hematol. 2015.